Publication | Open Access
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma
31
Citations
27
References
2020
Year
PTEN may be a biomarker and therapeutic target in patients with metastatic RCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1